COMUNICADO: Meta-análisis de estudios clínicos sobre SPIRIVA(R) (y 2)

10. O'Donnell DE, Fluge T, Gerken F, et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J. 2004 23(6):832-48

11. Brusasco V, Hodder R, Miravitlles M, et al. Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD. Thorax 2003;58:399-404.

12. Pocket Guide to COPD diagnosis, management, and prevention - A guide for healthcare professionals. Global Initiative for Chronic Obstructive Lung Disease. Disponible en: http://www.goldcopd.com

Boehringer Ingelheim GmbH, Judith von Gordon, división de comunicaciones corporativas, teléfono: +49-6132-77-35-82